If I had a gene test, what would I have and who would I tell?

Lancet

Volumn 354, Issue SUPPL.1, 1999, Pages 35-37

  Motulsky, Arno G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CLINICAL GENETICS; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC SCREENING; HEALTH INSURANCE; HUMAN; HUNTINGTON CHOREA; LIFESTYLE; MASS SCREENING; MEDICAL ETHICS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032806126     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(99)90436-1     Document Type: Article

References (24)

1. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press, 1994.
2. Reilly PR. Rethinking risks to human subjects in genetic research. Am J Hum Genet 1998; 63: 682-85.
3. Motulsky AG, Brunzell JD. The genetics of coronary artherosclerosis. In: King RA, Rotter JI, Motulsky AG, eds. Genetic basis of common diseases. Oxford: Oxford University Press, 1992: 150-69.
4. Baron H, Fung S, Aydin A, Bahring S, Luft FC, Schuster H. Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia. Nat Biotechnol 1996; 14: 1279-82.
5. Herrera VL, Ruiz-Opazo N. Genetic analysis of hypertension in animal models and human hypertensive patients. J Hypertens Suppl 1994; 12: S47-55.
6. Brodaty H, Conneally M, Gauthier S, Jennings C, Lennox A, Lovestone S. Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc Disord 1995; 9: 182-87.
7. Levy-Lahad E, Tsuang D, Bird TD. Recent advances in the genetics of Alzheimer's disease. J Geriatr Psychiatry Neural 1998; 11: 42-54.
8. Poirier J. Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease. J Psychiatry Neurosci 1999; 24: 147-53.
9. Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997; 60: 284-95.
10. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336: 823-27.
11. Powell SM. Direct analysis for familial adenomatous polyposis mutations. Methods Mol Biol 1998; 92: 251-66.
12. Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998; 62: 1290-301.
13. Lynch HT, Smyrk TC. Classification of familial adenomatous polyposis: a diagnostic nightmare. Am J Hum Genet 1998; 62: 1288-89.
14. Gryfe R, di Nicola N, Lal G, Gallinger S, Redston M. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 1999; 64: 378-84.
15. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339: 511-18.
16. Farrington SM, Lin-Goerke J, Ling J, et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998; 63: 749-59.
17. Ruschoff J, Wallinger S, Dietmaier W, et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 1998; 95: 11301-06.
18. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 1999; 64: 963-70.
19. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-95.
20. Devilee P. BRCA1 and BRCA2 testing: weighing the demand against the benefits. Am J Hum Genet 1999; 64: 943-48.
21. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999; 19: 511-18.
22. Bothwell TH, Charlton RW, Motulsky AG. Hemochromatosis. In: Scriver CR, Beaudet AL, Sly D, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th edn. New York: McGraw Hill, 1995.
23. Beutler E, Gelbart T. HLA-H mutations in the Ashkenazi Jewish population. Blood Cells Mol Dis 1997; 23: 95-98.
24. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998; 280: 173-78.